![\"Fangzhou](\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/05\/912b0b077ef808f302b710d614115ef6.png\")
Fangzhou Inc. <\/p>\n Fangzhou Inc. <\/p>\n
GUANGZHOU, China, May 19, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (\u201cFangzhou\u201d or the \u201cCompany\u201d) (HKEX: 06086), a leading provider of AI\u2011driven Internet healthcare solutions, was invited to attend the 2026 Guangzhou Artificial Intelligence and Intelligent Autonomous Systems Innovation Development Promotion Conference (the \u201cConference\u201d), where the Company was recognized for its technological innovation in \u201cAI + chronic disease services.\u201d<\/p>\n
Fangzhou Ranked among 2025 Guangzhou AI Innovation \u201cMost Promising Enterprises\u201d <\/p>\n
Fangzhou Ranked among 2025 Guangzhou AI Innovation \u201cMost Promising Enterprises\u201d<\/p>\n
The Conference brought together nearly 200 representatives from government agencies, research institutions, industry leaders, and financial institutions to showcase advances in artificial intelligence and strengthen collaboration across the innovation ecosystem.<\/p>\n
During the event, Fangzhou\u2019s subsidiary, Guangzhou Fangzhou Information Technology Co., Ltd., was named to the \u201c2025 Guangzhou Artificial Intelligence Innovation Development List\u201d under the category of \u201cMost Promising Enterprise.\u201d\u00a0This recognition marked the company\u2019s second consecutive year on the list, following its selection in 2024, underscoring growing industry recognition of Fangzhou\u2019s technological capabilities, service innovation, and contribution to the development of AI\u2011driven healthcare solutions.<\/p>\n
Fangzhou has expanded its \u201cAI + H2H (Hospital\u2011to\u2011Home)\u201d smart healthcare ecosystem, leveraging AI technology to address longstanding challenges in chronic disease management. In 2026, Fangzhou further refined its strategy to position itself as a trusted long\u2011term health partner for chronic disease patients, with the goal of building a comprehensive care model centered on continuous care and long\u2011term patient engagement. Powered by its proprietary XingShi Large Language Model, the Company has integrated AI technologies across online consultation, health management, and long\u2011term follow\u2011up services, extending professional healthcare support beyond traditional clinical settings.<\/p>\n
As artificial intelligence increasingly reshapes the healthcare industry, the Conference served as a platform to strengthen connections between innovation, industry, capital, and talent, supporting the coordinated development of the AI and healthcare industries. Fangzhou will continue strengthening its AI technology foundation, expanding the accessibility of chronic disease services through digital innovation, while helping advance the development of China\u2019s AI healthcare sector in support of the broader Healthy China initiative.<\/p>\n
About Fangzhou Inc.<\/p>\n
Fangzhou Inc. (HKEX: 06086) is China\u2019s leading online chronic disease management platform, serving 56.4 million registered users and 251,000 physicians as of December 31, 2025. The Company specializes in delivering tailored medical care and AI\u2011enabled precision medicine solutions. For more information, visit https:\/\/investors.jianke.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Fangzhou Inc. GUANGZHOU, China, May 19, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (\u201cFangzhou\u201d or the \u201cCompany\u201d) (HKEX: 06086),…\n","protected":false},"author":2,"featured_media":43422,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,25,387,26462,26461,26466,26460,26465,26467,26463,26459,26468,26464,6163],"class_list":["post-43421","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ai","tag-ai","tag-artificial-intelligence","tag-china","tag-chronic-disease","tag-chronic-disease-management","tag-fangzhou","tag-fangzhou-inc","tag-guangzhou","tag-healthcare-industry","tag-healthcare-solutions","tag-intelligent-autonomous-systems-innovation-development-promotion-conference","tag-service-innovation","tag-technological-innovation","tag-the-company"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/43421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=43421"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/43421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/43422"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=43421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=43421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=43421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}